Registry for Intra-Operative Radiotherapy During Breast Conserving Surgery in Patients With Early Stage Breast Cancer
Part of paid clinical trials in Santa Monica, California.
- Sponsor
- Saint John's Cancer Institute
- Study ID
- NCT04603209
- Status
- Recruiting
Conditions
- Breast Carcinoma in Situ
- Breast Neoplasms
- Early-stage Breast Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Intraoperative Radiation Therapy (IORT) — RADIATIONIORT involving 50kV Xrays to a dose of 20 Gy during breast-conserving surgery
Study Details
This is a prospective, registry study that will enroll all women with early stage breast cancer who will be treated with intraoperative radiotherapy (IORT) during breast-conserving surgery. The purpose of this study is to further validate the long-term effectiveness and safety of this treatment method. We aim to assess short and long-term patient outcomes associated with IORT, including perioperative complications, local and distance disease recurrences, as well as disease-free survival and overall survival.
Key Dates
- Start date
- Oct 3, 2018
- Status verified
- Apr 2024
- Primary completion
- Oct 3, 2028
- Completion
- Oct 3, 2028
Study Design
- Enrollment
- 1,000 participants (estimated)
Arms
- Arm: IORTAll participants who plan to undergo partial mastectomy for treatment of early stage breast cancer will be considered for eligibility for IORT. Patient with single breast cancer less than 3cm in disease span, clinical negative axillary node will be offered the option of having IORT. If IORT is delivered following surgical resection of the tumor they will be followed in this registry for short and long term outcomes.
Primary Outcome Measure
Disease Recurrence [ Time Frame: 5 years ]
Central Contacts
- Janie Grumley, MD(310) 582-7100
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| John Wayne Cancer Institute, Providence Saint John's Health Center | Santa Monica | California | 90404 | Robert Wollman, MD (SUB_INVESTIGATOR) Lisa Chaiken, MD (SUB_INVESTIGATOR) |
Find similar trials in Santa Monica, CA
By condition
By specialty
Related Studies
- I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPHASE2 · Recruiting · QuantumLeap Healthcare Collaborative · Birmingham, Alabama
- Women Informed to Screen Depending on Measures of Risk (Wisdom Study)Recruiting · University of California, San Francisco · Birmingham, Alabama
- Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast CancerPHASE2 · Recruiting · Jonsson Comprehensive Cancer Center · Fullerton, California
- A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyPHASE2 · Recruiting · GlaxoSmithKline · Tucson, Arizona